Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Infectious Diseases

• Publication date

  2016-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/civ808PMID 26349552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections

  2015influential reference
• Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond

  2015cited by this paper
• Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.

  2014cited by this paper
• A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.

  2014cited by this paper
• Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?

  2013cited by this paper
• Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement.

  2013cited by this paper
• Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus

  2013cited by this paper
• β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone

  2013cited by this paper
• Prospective Genotyping of Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Isolates by Use of a Novel, Highly Discriminatory Binary Typing System

  2012cited by this paper
• Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.

  2011cited by this paper
• Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand

  2009cited by this paper
• Mathematical Statistics with Applications

  2009cited by this paper
• Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.

  2009cited by this paper
• Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

  2007cited by this paper
• Impact of Empirical-Therapy Selection on Outcomes of Intravenous Drug Users with Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus

  2007cited by this paper
• Four cases of nafcillin-associated acute interstitial nephritis in one institution

  2007cited by this paper
• Vancomycin: does it still have a role as an antistaphylococcal agent?

  2007cited by this paper
• The pharmacokinetic and pharmacodynamic properties of vancomycin.

  2006cited by this paper
• Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

  2006cited by this paper
• Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants.

  2006cited by this paper
• Methicillin‐resistant Staphylococcus aureus in the Australian community: an evolving epidemic

  2006influential reference
• Diagnosis and management of Staphylococcus aureus bacteraemia

  2005cited by this paper
• Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.

  2003influential reference
• Therapeutic Guidelines: Antibiotic. Version 11.

  2001cited by this paper
• Community Strain of Methicillin-Resistant Staphylococcus aureus Involved in a Hospital Outbreak

  1999cited by this paper
• Retrospective Evaluation of Therapies for Staphylococcus aureus Endocarditis

  1997cited by this paper
• Effectiveness of Cloxacillin with and without Gentamicin in Short-Term Therapy for Right-Sided Staphylococcus aureus Endocarditis

  1996cited by this paper
• Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

  1990cited by this paper
• Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study.

  1982cited by this paper

• Natural product honokiol exerts anti-methicillin resistant Staphylococcus aureus infection activity by targeting pyruvate kinase to inhibit glucose metabolism.

  2026cites this paper
• Continuous versus intermittent vancomycin infusions in critically ill children with gram-positive bacterial infections: a randomized controlled trial

  2026cites this paper
• Subphenotype- and complication-guided adjunctive fosfomycin versus standard monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two randomised trials.

  2026cites this paper
• Navigating the Challenges in Staphylococcus aureus Bloodstream Infection: A Practical Guide to Management.

  2025cites this paper
• β-Lactam Adjunctive Therapy Compared to Vancomycin or Daptomycin Monotherapy in Adult Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: An Update Systematic Review, Meta-Analysis, and Trial Sequential Analysis

  2025cites this paper
• Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system

  2025cites this paper
• Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review

  2025cites this paper
• Efficacy of linezolid in monotherapy q12h versus q8h versus combined with daptomycin in the treatment of experimental endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus strains.

  2025cites this paper
• Management of Staphylococcus aureus Bacteremia: A Review.

  2025cites this paper
• Management of methicillin-resistant Staphylococcus aureus bloodstream infections: a comprehensive narrative review of available evidence focusing on current controversies and the challenges ahead

  2025cites this paper
• Phage-inspired targeting of antibiotic-loaded polymeric micelles for enhanced therapeutic efficacy against monomicrobial sepsis.

  2025cites this paper
• Vancomycin Area Under the Curve to Minimum Inhibitory Concentration Ratio for Treatment Effectiveness in Pediatric and Neonatal Staphylococcal Infections: A Systematic Review.

  2025cites this paper
• Atromentin B, Obtained by Microbial Fermentation and Total Synthesis, Potentiates the Activity of β-Lactams Against Methicillin-Resistant Staphylococcus aureus.

  2025cites this paper
• Advances and updates in antibiotic combination therapy

  2025cites this paper
• Acute Kidney Injury Associated with the Concomitant Use of Vancomycin and Piperacillin-Tazobactam

  2025cites this paper
• Ceftaroline Fosamil for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Real-World Comparative Clinical Outcomes Study

  2024cites this paper
• Early initiation of ceftaroline-based combination therapy for methicillin-resistant Staphylococcus aureus bacteremia

  2024influential citation
• Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis

  2024cites this paper
• Clinical outcome of combination of vancomycin and ceftaroline versus vancomycin monotherapy for treatment of methicillin resistant Staphylococcus aureus bloodstream infection

  2024cites this paper
• Which trial do we need? Combination therapy with daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of Methicillin-resistant Staphylococcus aureus bacteremia.

  2024cites this paper
• A Comprehensive Review of Nanomaterials as Potential Weapons against Multidrug-Resistant Staphylococcus aureus.

  2024cites this paper
• The Complex Intracellular Lifecycle of Staphylococcus aureus Contributes to Reduced Antibiotic Efficacy and Persistent Bacteremia

  2024cites this paper
• Surgical Site Infections with MRSA in young Patients

  2024cites this paper
• Effect of gallium nitrate on the antibacterial activity of vancomycin in methicillin-sensitive and resistant Staphylococcus aureus

  2024cites this paper
• Short versus long duration of ceftaroline combination therapy and outcomes in persistent or high-grade MRSA bacteremia: A retrospective single-center study

  2024cites this paper
• Combination of Antistaphylococcal β-Lactam With Standard Therapy Compared to Standard Therapy Alone for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia: A Post Hoc Analysis of the CAMERA2 Trial Using a Desirability of Outcome Ranking Approach

  2024cites this paper
• A Retrospective Cohort Study Comparing Dual Therapy With Ceftaroline With Vancomycin or Daptomycin Monotherapy for High-Grade or Persistent MRSA Bacteremia

  2024cites this paper
• Clinical Outcomes of Ceftaroline Fosamil in the Treatment of Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia

  2023cites this paper
• Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future

  2023cites this paper
• Measuring beta-lactam minimum inhibitory concentrations in Staphylococcus aureus in the clinical microbiology laboratory: pinning the tail on the donkey

  2023cites this paper
• Fosfomycin as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia: A case series and review of the literature.

  2023cites this paper
• Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistry.

  2023cites this paper
• Impact of Early Chemotherapy Resumption on the Outcome after Staphylococcus aureus Bacteremia in Patients with Solid Tumors: A Retrospective Study in a Single Tertiary Cancer Center in Japan

  2023cites this paper
• Optimal drug therapy for Staphylococcus aureus bacteraemia in adults

  2023cites this paper
• Guía de práctica clínica colombiana para el tratamiento de infecciones bacterianas de piel y tejidos blandos superficiales en Población pediátrica

  2023cites this paper
• Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment

  2023cites this paper
• Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia.

  2023cites this paper
• Desirability of outcome ranking and quality life measurement for antimicrobial research in organ transplantation

  2022cites this paper
• Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network Meta-Analysis

  2022cites this paper
• Persistent MRSA Bacteremia: Resetting the Clock for Optimal Management.

  2022cites this paper
• Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence

  2022cites this paper
• Combination of Sanguisorbigenin and Conventional Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus: Inhibition of Biofilm Formation and Alteration of Cell Membrane Permeability

  2022cites this paper
• Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance

  2022cites this paper
• How generalizable are randomized controlled trials (RCTs) in Staphylococcus aureus bacteremia? A description of the mortality gap between RCTs and observational studies.

  2022cites this paper
• Thérapeutique des infections à staphylocoques

  2022cites this paper
• PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: An in vivo study.

  2022cites this paper
• An Update on Treatment Options for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: A Systematic Review

  2022cites this paper
• A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications for Hospitalized Patients in 2021

  2022cites this paper
• Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial

  2022cites this paper
• Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant Staphylococcus aureus Bacteremia—A Meta-Analysis

  2022cites this paper
• Subinhibitory Concentrations of Antibiotics Exacerbate Staphylococcal Infection by Inducing Bacterial Virulence

  2022cites this paper
• Antimicrobial Resistance in Staphylococcus aureus

  2021cites this paper
• Cytokine measurements add value to clinical variables in predicting outcomes for Staphylococcus aureus bacteremia

  2021cites this paper
• What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant Staphylococcus aureus bacteraemia? A review

  2021cites this paper
• CLOISITE 10A AS AN EFFECTIVE ANTIBACTERIAL AGENT IN POLYMER MATRICES: ROLE OF NANOSCALE ROUGHNESS AND INTERFACIAL INTERACTIONS

  2021cites this paper
• Methicillin-Resistant Staphylococcus Aureus Bacteremia: Epidemiology, Clinical Characteristics, Risk Factors, and Outcomes in a Tertiary Care Center in Riyadh, Saudi Arabia

  2021cites this paper
• Dosing Considerations for Combination Antistaphylococcal β-Lactam and Glyco/lipopeptide Salvage Therapy for Resistant Gram-Positive Infections: A Systematic Review

  2021cites this paper
• Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?

  2021cites this paper
• Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: A Systematic Review and Meta-Analysis

  2021cites this paper
• Current Paradigms of Combination therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination and For Which Patients?

  2021cites this paper
• Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.

  2021cites this paper
• How I manage a patient with MRSA bacteraemia.

  2021cites this paper
• The Role of mprF Mutations in Seesaw Effect of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Isolates

  2021cites this paper
• The Effect of Combination Therapy on Mortality and Adverse Events in Patients with Staphylococcus aureus Bacteraemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  2021cites this paper
• Select controversies in the management of methicillin-resistant Staphylococcus aureus bacteremia: answers and remaining questions from recent evidence

  2021cites this paper
• Significant Publications on Infectious Diseases Pharmacotherapy in 2020

  2021cites this paper
• Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.

  2021cites this paper
• Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline

  2021influential citation
• Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant Staphylococcus aureus Bacteremia: STAPH Study

  2021cites this paper
• Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK

  2021cites this paper
• Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study

  2021cites this paper
• Current Challenges in the Management of Infective Endocarditis

  2021cites this paper
• Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis

  2020cites this paper
• Combination Therapy for MRSA Bacteremia: To β or Not to β?

  2020cites this paper
• In Vitro Synergistic Effect of Vancomycin and Some Antibacterial Agents Against Clinical Methicillin-Resistant and Sensitive Staphylococcus aureus Isolates

  2020cites this paper
• Measuring patient centred long term outcome following a bloodstream infection: a pilot study.

  2020cites this paper
• Using genomics to understand meticillin- and vancomycin-resistant Staphylococcus aureus infections

  2020cites this paper
• Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial

  2020cites this paper
• Adverse reactions of vancomycin in humans

  2020cites this paper
• Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time.

  2020cites this paper
• Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.

  2020cites this paper
• Therapy of Staphylococcus aureus bacteremia: Evidences and challenges.

  2020cites this paper
• Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish

  2020cites this paper
• De Novo Designed Hexadecapeptides Synergize Glycopeptide Antibiotics Vancomycin and Teicoplanin against Pathogenic Klebsiella pneumoniae via Disruption of Cell Permeability and Potential.

  2020cites this paper
• Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis

  2020cites this paper
• The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

  2020cites this paper
• Issues in Therapeutics of Some Bacterial Infections: Vancomycin Use, Osteomyelitis, Endocarditis, and Staphylococcus aureus Bacteremia

  2020cites this paper
• Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia

  2020cites this paper
• Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: A prospective cohort study.

  2020cites this paper
• Combination of Vancomycin or Daptomycin and Beta‐lactam Antibiotics: A Meta‐analysis

  2020cites this paper
• Combination therapy for Staphylococcus aureus bacteremia: hopes dashed again.

  2020cites this paper
• Adjunctive Daptomycin in the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Randomized Controlled Trial.

  2020cites this paper
• Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial

  2020cites this paper
• Reply to Volpicelli et al.

  2020cites this paper
• Updates on Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia

  2020cites this paper
• Henry Ford Health System

  2020cites this paper
• Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.

  2020cites this paper
• Systematic review and meta-analysis of the efficacy and safety of vancomycin combined with β-lactam antibiotics in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections.

  2020cites this paper
• The antivirulence compound myricetin possesses remarkable synergistic effect with antibacterials upon multidrug resistant Staphylococcus aureus.

  2020cites this paper
• Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar

  2020cites this paper